Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience.

Ferdinando D'AmicoOlga TasopoulouGionata FiorinoAlessandra ZilliFederica FurfaroMariangela AlloccaPierpaolo SileriAntonino SpinelliLaurent Peyrin-BirouletSilvio Danese

Published in: Inflammatory bowel diseases (2022)

Operated CD patients treated early with biologics experience decreased rates of endoscopic recurrence and improved long-term outcomes.

Keyphrases

end stage renal disease
ultrasound guided
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
stem cells
mesenchymal stem cells
bone marrow
cell therapy